Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
Cowen and Company 32nd Annual Health Care Conference on
Monday, March 5, 2012, at 4:50 p.m. ET in Boston, Massachusetts.
A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking
to discover, develop, and deliver to patients best-in-class medicines
for difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity’s programs in the inhibition
of the Hedgehog pathway, the Hsp90 chaperone system and
phosphoinositide-3-kinase are evidence of its innovative approach to
drug discovery and development. For more information on Infinity, please
refer to the company’s website at www.infi.com.